The effectiveness of therapies perennial allergic rhinitis associated with fungi of the genus of Candida, in children

The purpose of research was to study the features of mucosal immunity in children with perennial allergic rhinitis (PAR) associated with fungi of Candida genus, for the improvement of the disease therapies. The study of mucosal immunity in 30 children aged from 3 to 18 years with PAR associated with fungi of the genus of Candida, revealed a high level of atopic type of response rates (eosinophilia, nasal secretion, increase secretory immunoglobulin - sIg - E and IL-4) due to lower anti-infective protection indicators (levels of interferon γ and sIgA, inhibition of neutrophil migration into nasal cavity and their functional activity). Inclusion complex therapy KAP associated with fungi of the genus Candida, immunomodulator polioxydonium administered intranasally in doses based on age, leads to reduced activity of allergic inflammation in the mucous membrane of the nasal cavity, which is manifested decrease in the level of eosinophils, sIgE and interleukin-4 in nasal secretions, as well as an increase in activity rates of anti-protection in the mucosa of the nasal cavity, which manifests an increase in the level of interferon γ, sIgA and activation of the functional activity of neutrophils in nasal secretions.

children, allergic rhinitis, fungi of Candida, polioxydonium